LG
EXAS

LaFleur & Godfrey’s Exact Sciences EXAS Stock Holding History

LaFleur & Godfrey’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,260
Closed -$241K – 137
2023
Q4 		$241K Sell
3,260
-45
-1% -$2.95K 0.04% 120
2023
Q3 		$225K Sell
3,305
-275
-8% -$23.3K 0.04% 113
2023
Q2 		$336K Buy
+3,580
New +$279K 0.05% 102
2022
Q3 		– Sell
-5,287
Closed -$208K – 122
2022
Q2 		$208K Sell
5,287
-7,935
-60% -$424K 0.03% 119
2022
Q1 		$924K Sell
13,222
-8,118
-38% -$593K 0.12% 88
2021
Q4 		$1.66M Buy
21,340
+4,750
+29% +$419K 0.21% 77
2021
Q3 		$1.58M Buy
16,590
+12,785
+336% +$1.35M 0.22% 77
2021
Q2 		$473K Buy
+3,805
New +$454K 0.07% 101

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LaFleur & Godfrey's EXAS Position: Q1 2024 in Review

LaFleur & Godfrey sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,260 shares — an estimated $241K sold.

LaFleur & Godfrey first reported a position in EXAS in Q2 2021 and held it in 8 quarters. The position peaked at $1.66M in Q4 2021. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • LaFleur & Godfrey reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • LaFleur & Godfrey sold 3,260 Exact Sciences shares in Q1 2024, an estimated $241K.
  • LaFleur & Godfrey first reported a position in Exact Sciences in Q2 2021 and held it in 8 quarters.
  • LaFleur & Godfrey's Exact Sciences position peaked at $1.66M in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on LaFleur & Godfrey's 13F filing for Q1 2024, filed 23 Apr 2024.